• FDA approves pregabalin extended-release for diabetic neuropathy

    6 days ago - By Healio

    The FDA approved pregabalin extended-release tablets CV as a once-daily therapy for the management of pain associated with diabetic peripheral neuropathy and postherpetic neuralgia, Pfizer announced in a press release.
    Pregabalin did not receive approval for the management of fibromyalgia, according to the release.
    “Lyrica CR was developed to offer patients an effective treatment option with the convenience of once-daily dosing,” James M. Rusnak, MD, PhD, chief development officer, internal medicine, Pfizer Global Product Development, said in a statement. “It
    Read more ...